Treatment of central serous chorioretinopathy with topical NSAIDs
Clicks: 280
ID: 5724
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
67.2
/100
280 views
224 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Treatment of central serous chorioretinopathy with topical NSAIDs Sepehr Bahadorani,1 Kyle Maclean,1 Kendall Wannamaker,1 Edward Rickie Chu,1 Nathan Gresores,2 Jeong-Hyeon Sohn,1 Roberto Diaz-Rohena,1 Michael A Singer21Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associates, San Antonio, TX, USACorrespondence: Michael A SingerMedical Center Ophthalmology Associates, 9157 Huebner Road, San Antonio, TX 78240, USA Tel +1 210 697 2020 Email msinger11| Reference Key |
sepehr2019treatmentclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sepehr Bahadorani;Kyle Maclean;Kendall Wannamaker;Edward Rickie Chu;Nathan Gresores;JeongÂ-Hyeon Sohn;Roberto DiazÂ-Rohena;Michael A Singer and |
| Journal | clinical ophthalmology |
| Year | 2019 |
| DOI | 10.2147/OPTH.S202047 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.